Sharon Shacham

This inventor holds 51 USPTO granted patents and 21 published patent applications, plus 6 CIPO patents and 15 EPO patents, primarily in Nuclear Transport Modulators. Top assignees: Karyopharm Therapeutics Inc., Epix Delaware, Inc., Biogen Ma Inc.. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharon Shacham. Retrieved from https://idiyas.com/inventor/sharon-shacham

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 51 (Patent Applications = 21)

% Patents Active = 78.4

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 15 (Patent Applications = 21)

Average Co-Inventor Count = 6.2

ph-index = 18

Forward Citations = 643(Granted Patents)

Forward Citations (Not Self Cited) = 299(Dec 10, 2025)

Location History:

Alfey Menashe, IL (2008 - 2011)
Chestnut Hill, MA (US) (2009 - 2016)
Newton, MA (US) (2009 - 2024)

Company Filing History:

30 out of 43

Karyopharm Therapeutics Inc.

Epix Pharmaceuticals, Inc.

patents

5. 2 out of 51

Microdose Therapeutx, Inc.

Nanotherapeutics, Inc.

patents

9. 1 out of 834,513

Other

patents

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Nuclear Transport Modulators

Hydrazide Compounds

Adenosine Analogs

Benzofuranyl Compounds

Wound Healing

Cancer Treatment

Substituted Compounds

Multicyclic Compounds

CRM1 Inhibitors

Carboxamide Compounds

Benzoxazolyl Compounds

Arylamine Compounds

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577225 - Nuclear transport modulators and uses thereof (2026-03-17),

2. 12331040 - Substituted benzofuranyl and benzoxazolyl compounds and uses thereof (2025-06-17),

3. 12291508 - Hydrazide containing nuclear transport modulators and uses thereof (2025-05-06),

4. 11945794 - Nuclear transport modulators and uses thereof (2024-04-02),

5. 11787771 - Hydrazide containing nuclear transport modulators and uses thereof (2023-10-17),

6. 11318120 - Nuclear transport modulators and uses thereof (2022-05-03),

7. 11124493 - Nuclear transport modulators and uses thereof (2021-09-21),

8. 11034660 - Hydrazide containing nuclear transport modulators and uses thereof (2021-06-15),

9. 11008309 - Substituted benzofuranyl and benzoxazolyl compounds and uses thereof (2021-05-18),

10. 10925859 - Nuclear transport modulators and uses thereof (2021-02-23),

11. 10722497 - Nuclear transport modulators and uses thereof (2020-07-28),

12. 10617677 - Nuclear transport modulators and uses thereof (2020-04-14),

13. 10544108 - Hydrazide containing nuclear transport modulators and uses thereof (2020-01-28),

14. 10407405 - Nuclear transport modulators and uses thereof (2019-09-10),

15. 10399963 - Substituted benzofuranyl and benzoxazolyl compounds and uses thereof (2019-09-03),

Title: The Innovative Mind of Sharon Shacham

Introduction: Sharon Shacham is a pioneering inventor based in Newton, MA, known for her groundbreaking work in the field of biotechnology.

Latest Patents: Sharon Shacham holds several patents related to novel therapeutic approaches for the treatment of cancer and other diseases. Her most recent patent focuses on a new method for targeting specific cellular pathways involved in tumor growth.

Career Highlights: With a background in molecular biology and biochemistry, Sharon Shacham has dedicated her career to developing innovative therapies that target the underlying mechanisms of disease. She has received numerous awards for her contributions to the field of biotechnology.

Collaborations: Throughout her career, Sharon Shacham has collaborated with leading researchers, pharmaceutical companies, and academic institutions to further the development of her inventions. Her collaborative spirit has led to the successful translation of her research into clinical applications.

Conclusion: Sharon Shacham's relentless pursuit of innovation and her passion for improving patient outcomes have solidified her reputation as a trailblazer in the field of biotechnology. Her work continues to inspire the next generation of inventors and researchers in the quest for novel therapeutic solutions.

Profile summary based on public USPTO records.